Powered by The first study of the safety and tolerability of MDMA-assisted psychotherapy in patients with alochol use disorder – the Bristol Imperial MDMA in Alcoholism Study (BIMA) – reported positive results this month. The open-label proof of concept study, led by David Nutt, demonstrated significant reductions in units of alcohol consumed. Now, more rigorous, double-blind studies will be…


Previous articleMindMed Announces C$19.5 Million Bought Deal Private Placement Offering
Next articleBetter Plant Appoints Branding Expert Perry Chua as Chief Creative Officer